|
|
||||||||
Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 1# Shuai Fu Yuan Hu Tong, Dong Dan, Beijing 100730, China
(Requests for offprints should be addressed to J Deng; Email: fygong5074{at}yahoo.com.cn)
The present study was performed to elucidate the effect of interleukin (IL)-6 on the human GH (hGH)-gene expression in GH3 rat pituitary tumor cells using stable transfection of the hGH promoter fused to a luciferase reporter gene. Our results showed that IL-6 (102104 U/ml) stimulated GH secretion and synthesis, and promoted the luciferase expression in stably transfected GH3 cells with the maximal action of 1.99 times above the control by 104 U/ml IL-6. Among the inhibitors of signaling transduction pathways, mitogen-activated protein kinase kinase (MAPKK/MEK) inhibitor PD98059 (40 µM) and p38 mitogen-activated protein kinase (MAPK) inhibitor SB203580 (5 µM) completely blocked the stimulatory effect of IL-6. Western blot analysis demonstrated that IL-6 indeed increased the activation of phosphorylated MEK and p38 MAPK in GH3 cells. Neither overexpression of Pit-1 nor inhibiting Pit-1 expression affected IL-6 induction of hGH-promoter activity. To identify the DNA sequence that mediated the effect of IL-6, six deletion constructs of hGH promoter were created. The stimulatory effect of IL-6 was abolished following deletion of the 196 to 132 bp fragment. In conclusion, our data show that IL-6 promotes GH secretion and synthesis by rat pituitary GH3 cells. The stimulatory effect of IL-6 on hGH-gene promoter appears to require the activation of MEK and p38 MAPK, and a fragment of promoter sequence that spans the 196 to 132 bp of the gene, but may be unrelated to Pit-1 protein.
This article has been cited by other articles:
![]() |
M. Lasa, B. Gil-Araujo, M. Palafox, and A. Aranda Thyroid Hormone Antagonizes Tumor Necrosis Factor-{alpha} Signaling in Pituitary Cells through the Induction of Dual Specificity Phosphatase 1 Mol. Endocrinol., February 1, 2010; 24(2): 412 - 422. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |